166 related articles for article (PubMed ID: 34638742)
1. Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes.
Vessières A; Quissac E; Lemaire N; Alentorn A; Domeracka P; Pigeon P; Sanson M; Idbaih A; Verreault M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638742
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line.
Ghiasvand S; Javidi MA; Mohammadian A; Mousavi SA; Shahriari F; Alavian F
Life Sci; 2021 Feb; 266():118874. PubMed ID: 33358904
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
5. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.
Facchini G; Ignarro RS; Rodrigues-Silva E; Vieira AS; Lopes-Cendes I; Castilho RF; Rogerio F
J Neurooncol; 2018 Feb; 136(3):435-443. PubMed ID: 29159775
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells.
Qu C; Ma J; Zhang Y; Han C; Huang L; Shen L; Li H; Wang X; Liu J; Zou W
Cancer Sci; 2019 Jan; 110(1):221-234. PubMed ID: 30417588
[TBL] [Abstract][Full Text] [Related]
10. Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.
Idlas P; Lepeltier E; Jaouen G; Passirani C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064748
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective Synthesis of Planar Chiral Ferrocifens that Show Chiral Discrimination in Antiproliferative Activity on Breast Cancer Cells.
Cunningham L; Wang Y; Nottingham C; Pagsulingan J; Jaouen G; McGlinchey MJ; Guiry PJ
Chembiochem; 2020 Oct; 21(20):2974-2981. PubMed ID: 32453493
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.
Verreault M; Schmitt C; Goldwirt L; Pelton K; Haidar S; Levasseur C; Guehennec J; Knoff D; Labussière M; Marie Y; Ligon AH; Mokhtari K; Hoang-Xuan K; Sanson M; Alexander BM; Wen PY; Delattre JY; Ligon KL; Idbaih A
Clin Cancer Res; 2016 Mar; 22(5):1185-96. PubMed ID: 26482041
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma entities express subtle differences in molecular composition and response to treatment.
Balça-Silva J; Matias D; Do Carmo A; Dubois LG; Gonçalves AC; Girão H; Canedo NHS; Correia AH; De Souza JM; Sarmento-Ribeiro AB; Lopes MC; Moura-Neto V
Oncol Rep; 2017 Sep; 38(3):1341-1352. PubMed ID: 28714013
[TBL] [Abstract][Full Text] [Related]
14. Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM).
Demeure K; Fack F; Duriez E; Tiemann K; Bernard A; Golebiewska A; Bougnaud S; Bjerkvig R; Domon B; Niclou SP
Mol Cell Proteomics; 2016 Feb; 15(2):481-92. PubMed ID: 26243272
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
17. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation).
Viswanathan A; Musa A; Murugesan A; Vale JR; Afonso CAM; Konda Mani S; Yli-Harja O; Candeias NR; Kandhavelu M
Cells; 2019 Dec; 8(12):. PubMed ID: 31842391
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens.
Lu C; Heldt JM; Guille-Collignon M; Lemaître F; Jaouen G; Vessières A; Amatore C
ChemMedChem; 2014 Jun; 9(6):1286-93. PubMed ID: 24803138
[TBL] [Abstract][Full Text] [Related]
19. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
20. α-Hydroxylactams as Efficient Entries to Diversely Functionalized Ferrociphenols: Synthesis and Antiproliferative Activity Studies.
Pigeon P; Gaschard M; Othman M; Salmain M; Jaouen G
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
